Delivery Order SPE2DB22D2007-SPE2DB25FJ3ZE
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,950.79 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5), 5-count units, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive process, representing a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under...
- The Defense Logistics Agency awarded a $3,951.77 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5), with a completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $1,372.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 pods on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods valued at $1,222.32. This competitive, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.73 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a Delivery Order valued at $3,775.06 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5), 5-pack units. The order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work from its corporate office location. This delivery order represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $9,989.48 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods on July 25, 2025, with a completion date of July 28, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to the vendor based in Conshohocken, Pennsylvania. This delivery order represents a relatively small-value transaction within the broader federal medical procurement landscape and will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,833.48 to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 pods (Generation 5) in 5-count packages. This firm fixed-price, non-set-aside contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The OmniPod 5 is an insulin delivery system widely used for diabetes management, and...
- The Defense Logistics Agency awarded a $1,804.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods. This non-set-aside competitive award was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical and...